| The goal of this two-year training program is to provide the fellow with specialized skills in clinical pharmacokinetic/pharmacodynamic/pharmacogenomic study design, methodology, and data analysis and presentation. The fellow will collaborate in ongoing clinical research investigations including studies of drug metabolism/transport, drug-drug interactions, drug-gene interactions, and dose-escalation/dose-safety/tolerability in addition to developing and initiating individual research projects. The program will provide ample opportunity for the fellow to gain expertise in pharmacokinetic data analysis (using software programs such as WinNonlin), statistical analysis, study protocol design, scientific writing, and grantsmanship. Opportunity to gain exposure in drug assay development and validation procedures will be provided, as will opportunities for advanced coursework in clinical research/drug development, clinical pharmacology, pharmacokinetics, biostatistics, and genetics. The fellow will attend scientific meetings (at least one per year) where he/she will present preliminary scientific data in abstract or poster form; manuscript preparation and publication will follow. The fellow will also have the opportunity to participate in clinical activities in the National Institute of Allergy and Infectious Diseases (NIAID) Outpatient HIV Clinic. Applicants are strongly encouraged to set up interviews at ASHP Midyear via Personal Placement Service (PPS). Formal applications are due by January 1. Applicants will be required to submit a Cover Letter/Letter of Interest, 3 professional letters of reference, a CV, and an unofficial transcript to be emailed directly to: Jomy George, PharmD, BCPS, AQ-ID Fellowship Director jomy.george@nih.gov |
